Cas no 102519-34-6 (Olean-12-en-28-oicacid, 2,3,23-trihydroxy-, (2a,3a,4a)-)
Olean-12-en-28-oicacid, 2,3,23-trihydroxy-, (2a,3a,4a)- Chemical and Physical Properties
Names and Identifiers
-
- Olean-12-en-28-oicacid, 2,3,23-trihydroxy-, (2a,3a,4a)-
- 2α,3α,23-Trihydroxyolean-12-en-28-oic acid
- 2,3,23-Trihydroxy-12-oleanen-28-oic acid
- 2a,3a,23-Trihydroxyolean-12-en-28-oic acid
- Isoarjunolicacid
- [ "" ]
- CHEBI:67913
- Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2alpha,3alpha,4alpha)-
- 2alpha,3alpha,23-trihydroxyolean-12-en-28-oic acid
- (4aS,6aR,6aS,6bR,8aR,9R,10S,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
- SCHEMBL5800081
- Q27136387
- (2alpha,3alpha)-2,3,23-trihydroxyolean-12-en-28-oic acid
- CHEMBL1774425
- Isoarjunolic acid
- FS-10082
- AKOS026674276
- 102519-34-6
- DA-60006
-
- Inchi: 1S/C30H48O5/c1-25(2)11-13-30(24(34)35)14-12-28(5)18(19(30)15-25)7-8-22-26(3)16-20(32)23(33)27(4,17-31)21(26)9-10-29(22,28)6/h7,19-23,31-33H,8-17H2,1-6H3,(H,34,35)/t19-,20+,21+,22+,23+,26-,27-,28+,29+,30-/m0/s1
- InChI Key: RWNHLTKFBKYDOJ-LHFSSXJCSA-N
- SMILES: O[C@@H]1[C@@H](C[C@@]2(C)[C@H]([C@]1(C)CO)CC[C@@]1(C)[C@]3(C)CC[C@@]4(C(=O)O)CCC(C)(C)C[C@H]4C3=CC[C@@H]12)O
Computed Properties
- Exact Mass: 488.35034
- Monoisotopic Mass: 488.35017463g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 4
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 35
- Rotatable Bond Count: 2
- Complexity: 941
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 10
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 5.8
- Topological Polar Surface Area: 98?2
Experimental Properties
- Color/Form: Powder
- PSA: 97.99
Olean-12-en-28-oicacid, 2,3,23-trihydroxy-, (2a,3a,4a)- Security Information
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:Store at 4 ℃, better at -4 ℃
Olean-12-en-28-oicacid, 2,3,23-trihydroxy-, (2a,3a,4a)- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | T66030-5mg |
(4aS,6aS,6bR,8aR,9R,10S,11R,12aR,12bR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylic acid |
102519-34-6 | ,HPLC≥95.0% | 5mg |
¥5280.0 | 2023-09-06 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN2684-1 mg |
2,3,23-Trihydroxy-12-oleanen-28-oic acid |
102519-34-6 | 1mg |
¥2435.00 | 2022-04-26 | ||
| TargetMol Chemicals | TN2684-5 mg |
2,3,23-Trihydroxy-12-oleanen-28-oic acid |
102519-34-6 | 98% | 5mg |
¥ 3,710 | 2023-07-11 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN2684-1 mL * 10 mM (in DMSO) |
2,3,23-Trihydroxy-12-oleanen-28-oic acid |
102519-34-6 | 1 mL * 10 mM (in DMSO) |
¥ 3810 | 2023-09-08 | ||
| TargetMol Chemicals | TN2684-5mg |
2,3,23-Trihydroxy-12-oleanen-28-oic acid |
102519-34-6 | 5mg |
¥ 3710 | 2024-07-20 | ||
| A2B Chem LLC | AA09687-5mg |
Isoarjunolic acid |
102519-34-6 | 95.0% | 5mg |
$660.00 | 2024-04-20 | |
| TargetMol Chemicals | TN2684-1 ml * 10 mm |
2,3,23-Trihydroxy-12-oleanen-28-oic acid |
102519-34-6 | 1 ml * 10 mm |
¥ 3810 | 2024-07-20 | ||
| TargetMol Chemicals | TN2684-5mg |
2,3,23-Trihydroxy-12-oleanen-28-oic acid |
102519-34-6 | 5mg |
¥ 3710 | 2024-07-24 | ||
| TargetMol Chemicals | TN2684-1 ml * 10 mm |
2,3,23-Trihydroxy-12-oleanen-28-oic acid |
102519-34-6 | 1 ml * 10 mm |
¥ 3810 | 2024-07-24 | ||
| Aaron | AR0008BN-5mg |
Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2α,3α,4α)- |
102519-34-6 | 95% | 5mg |
$830.00 | 2025-02-13 |
Olean-12-en-28-oicacid, 2,3,23-trihydroxy-, (2a,3a,4a)- Related Literature
-
Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
-
Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
-
Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
-
Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
Additional information on Olean-12-en-28-oicacid, 2,3,23-trihydroxy-, (2a,3a,4a)-
Comprehensive Overview of Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2α,3α,4α)- (CAS No. 102519-34-6)
Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2α,3α,4α)- is a naturally occurring triterpenoid compound with significant biological and pharmacological potential. This compound, identified by its CAS number 102519-34-6, belongs to the oleanane class of triterpenes, which are widely studied for their diverse therapeutic properties. The unique structural features of this molecule, including its hydroxyl groups at positions 2, 3, and 23, contribute to its bioactivity and make it a subject of interest in both academic and industrial research.
The chemical structure of Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2α,3α,4α)- is characterized by a pentacyclic framework, which is common among triterpenoids. The presence of multiple hydroxyl groups enhances its solubility and interaction with biological targets, making it a promising candidate for drug development. Researchers have explored its potential in various fields, including anti-inflammatory, antioxidant, and anticancer applications. These properties align with current trends in natural product research, where there is a growing demand for plant-derived compounds with minimal side effects.
One of the most compelling aspects of Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2α,3α,4α)- is its role in traditional medicine. Many cultures have used plants rich in this compound for centuries to treat ailments such as inflammation and infections. Modern scientific studies have validated some of these traditional uses, highlighting the compound's ability to modulate immune responses and oxidative stress. This intersection of traditional knowledge and contemporary science is a hot topic in the pharmaceutical industry, as it offers a sustainable approach to drug discovery.
In recent years, the demand for natural bioactive compounds has surged, driven by consumer preferences for safer and more sustainable health solutions. Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2α,3α,4α)- fits perfectly into this trend, as it is derived from renewable plant sources and exhibits low toxicity. Its potential applications in cosmeceuticals and nutraceuticals are also being explored, with studies suggesting benefits for skin health and metabolic disorders. These findings are particularly relevant in today's market, where there is a strong focus on holistic wellness.
The synthesis and extraction of Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2α,3α,4α)- are areas of active research. While the compound can be isolated from natural sources, synthetic routes are being developed to ensure a consistent and scalable supply. Advances in green chemistry have enabled more efficient extraction methods, reducing environmental impact and aligning with global sustainability goals. These developments are critical for meeting the growing demand for this compound in various industries.
From a commercial perspective, Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2α,3α,4α)- is gaining traction in the pharmaceutical and cosmetic sectors. Its multifunctional properties make it a versatile ingredient, capable of addressing multiple health and beauty concerns. Market analysts predict a steady increase in its adoption, particularly in regions with a strong emphasis on natural and organic products. This aligns with broader consumer trends favoring transparency and efficacy in product formulations.
In conclusion, Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2α,3α,4α)- (CAS No. 102519-34-6) is a compound of immense scientific and commercial interest. Its unique chemical structure, coupled with its broad range of biological activities, positions it as a valuable asset in the fields of medicine, cosmetics, and nutraceuticals. As research continues to uncover its full potential, this triterpenoid is poised to play a pivotal role in the development of next-generation therapeutic and wellness products.